Kalaris Therapeutics, Inc. (KLRS) stock
KLRSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.43−0.03 (-2.05%)
Close on Nov 17, 2026Market cap $34.04MP/E –Yield –
Kalaris Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Kalaris Therapeutics's profit margin for the twelve months ending Dec 31, 2019 was -14447.9%. For fiscal 2019 it was -14447.9%.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | -14447.9% | – |
See a number that looks wrong?